Silence Therapeutics
Stock Forecast, Prediction & Price Target
Silence Therapeutics Financial Estimates
Silence Therapeutics Revenue Estimates
Silence Therapeutics EBITDA Estimates
Silence Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $12.41M N/A | $17.50M 40.96% | $25.37M 44.99% | Avg: $31.99M Low: $5.89M High: $73.04M avg. 26.09% | Avg: $24.29M Low: $12.14M High: $43.24M avg. -24.07% | Avg: $58.77M Low: $29.38M High: $104.64M avg. 141.95% | Avg: $164.77M Low: $82.36M High: $293.34M avg. 180.33% |
Net Income
% change YoY
| $-39.41M N/A | $-40.48M -2.73% | $-43.26M -6.86% | Avg: $-14.77M Low: $-24.44M High: $-1.62M avg. 65.84% | Avg: $-20.00M Low: $-40.29M High: $-6.99M avg. -35.36% | Avg: $-20.10M Low: $-40.49M High: $-7.03M avg. -0.49% | Avg: $-9.64M Low: $-19.42M High: $-3.37M avg. 52.02% |
EBITDA
% change YoY
| $-45.37M N/A | $-47.88M -5.52% | $-49.77M -3.95% | Avg: $-31.99M Low: $-73.04M High: $-5.89M avg. 35.72% | Avg: $-24.29M Low: $-43.24M High: $-12.14M avg. 24.07% | Avg: $-58.77M Low: $-104.64M High: $-29.38M avg. -141.95% | Avg: $-164.77M Low: $-293.34M High: $-82.36M avg. -180.33% |
EPS
% change YoY
| -$1.33 N/A | -$1.26 5.26% | -$1.17 7.14% | Avg: -$0.4 Low: -$0.66 High: -$0.04 avg. 65.95% | Avg: -$0.54 Low: -$1.09 High: -$0.19 avg. -35.36% | Avg: -$0.54 Low: -$1.09 High: -$0.19 avg. -0.49% | Avg: -$0.26 Low: -$0.52 High: -$0.09 avg. 52.02% |
Operating Expenses
% change YoY
| $50.77M N/A | $55.21M 8.74% | $64.66M 17.10% | Avg: $291.88M Low: $53.82M High: $666.36M avg. 351.41% | Avg: $221.61M Low: $110.78M High: $394.54M avg. -24.07% | Avg: $536.21M Low: $268.04M High: $954.61M avg. 141.95% | Avg: $1.50B Low: $751.42M High: $2.67B avg. 180.33% |
FAQ
What is Silence Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.50% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -24.44M, average is -14.77M and high is -1.62M.
What is Silence Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 81.07% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $5.89M, average is $31.99M and high is $73.04M.
What is Silence Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 20.52% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.66, average is -$0.4 and high is $-0.04.
What is the best performing analyst?
In the last twelve months analysts have been covering Silence Therapeutics stock. The most successful analyst is Keay Nakae.